PRMT5 and hepatocellular carcinoma: In addition, PRMT5 can stimulate liver glucose metabolism, (Tsai et al., 2013) and activate CDK4-pRB-E2F-mediated transcription under glucose induction to promote HCC cell cycle progression (Yang et al., 2016).